{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T09:44:20Z","timestamp":1775468660690,"version":"3.50.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s11910-019-0924-0","type":"journal-article","created":{"date-parts":[[2019,2,9]],"date-time":"2019-02-09T05:03:22Z","timestamp":1549688602000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Sleep Complaints, Sleep and Breathing Disorders in Myotonic Dystrophy Type 2"],"prefix":"10.1007","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4505-2600","authenticated-orcid":false,"given":"Andrea","family":"Romigi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelangelo","family":"Maestri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmine","family":"Nicoletta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Vitrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Caccamo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele","family":"Siciliano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrica","family":"Bonanni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Centonze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Sanduzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,9]]},"reference":[{"key":"924_CR1","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1136\/jnnp.2008.158261","volume":"81","author":"C Turner","year":"2010","unstructured":"Turner C, Hilton-Jones D. The myotonic dystrophies: diagnosis and management. J Neurol Neurosurg Psychiatry. 2010;81:358\u201367.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"924_CR2","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/S1474-4422(12)70204-1","volume":"11","author":"B Udd","year":"2012","unstructured":"Udd B, Krahe R. The myotonic dystrophies: molecular, clinical, and therapeutic challenges. Lancet Neurol. 2012;11:891\u2013905.","journal-title":"Lancet Neurol"},{"issue":"5049","key":"924_CR3","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1126\/science.1546325","volume":"255","author":"M Mahadevan","year":"1992","unstructured":"Mahadevan M, Tsilfidis C, Sabourin L, Shutler G, Amemiya C, Jansen G, et al. Myotonic dystrophy mutation: an unstable CTG repeat in the 3\u2032 untranslated region of the gene. Science. 1992;255:1253\u20135.","journal-title":"Science"},{"issue":"5531","key":"924_CR4","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1126\/science.1062125","volume":"293","author":"C. L. Liquori","year":"2001","unstructured":"Liquori CL, Ricker K, Moseley ML, Jacobsen JF, Kress W, Naylor SL, et al. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science. 2001;293:864\u20137.","journal-title":"Science"},{"key":"924_CR5","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3389\/fneur.2018.00303","volume":"9","author":"S Wenninger","year":"2018","unstructured":"\u2022 Wenninger S, Montagnese F, Schoser B. Core clinical phenotypes in myotonic dystrophies. Front Neurol. 2018;9:303 A comprehensive revision of clinical phenotypes of both DM1 and DM2.","journal-title":"Front Neurol"},{"key":"924_CR6","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1007\/s13311-018-00679-z","volume":"15","author":"S LoRusso","year":"2018","unstructured":"LoRusso S, Weiner B, Arnold WD. Myotonic dystrophies: targeting therapies for multisystem disease. Neurotherapeutics. 2018;15:872\u201384.","journal-title":"Neurotherapeutics"},{"key":"924_CR7","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1007\/s00415-017-8653-2","volume":"264","author":"F Montagnese","year":"2017","unstructured":"\u2022\u2022 Montagnese F, Mondello S, Wenninger S, Kress W, Schoser B. Assessing the influence of age and gender on the phenotype of myotonic dystrophy type 2. J Neurol. 2017;264:2472\u201380 A detailed clinical chacterization of a large cohort of DM2 patients investigating the role of age and gender influencing DM2 phenotype.","journal-title":"J Neurol"},{"key":"924_CR8","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jsmc.2015.10.005","volume":"11","author":"AM Fermin","year":"2016","unstructured":"\u2022 Fermin AM, Afzal U, Culebras A. Sleep in neuromuscular diseases. Sleep Med Clin. 2016;11:53\u201364 A comprehensive review regarding the relationship between sleep disorders and neuromuscular disorders.","journal-title":"Sleep Med Clin"},{"key":"924_CR9","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1007\/s11910-013-0340-9","volume":"13","author":"L Laberge","year":"2013","unstructured":"Laberge L, Gagnon C, Dauvilliers Y. Daytime sleepiness and myotonic dystrophy. Curr Neurol Neurosci Rep. 2013;13:340.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"924_CR10","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s11325-013-0921-5","volume":"18","author":"MLE Bianchi","year":"2014","unstructured":"Bianchi MLE, Losurdo A, Di Blasi C, Santoro M, Masciullo M, Conte G, et al. Prevalence and clinical correlates of sleep disordered breathing in myotonic dystrophy types 1 and 2. Sleep Breath. 2014;18:579\u201389.","journal-title":"Sleep Breath"},{"key":"924_CR11","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1136\/jnnp.2009.192591","volume":"81","author":"AA Tieleman","year":"2010","unstructured":"Tieleman AA, Knoop H, van de Logt A-E, Bleijenberg G, van Engelen BGM, Overeem S. Poor sleep quality and fatigue but no excessive daytime sleepiness in myotonic dystrophy type 2. J Neurol Neurosurg Psychiatry. 2010;81:963\u20137.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"924_CR12","doi-asserted-by":"crossref","unstructured":"Romigi A, Albanese M, Placidi F, Izzi F, Liguori C, Marciani MG, et al. Sleep disorders in myotonic dystrophy type 2: a controlled polysomnographic study and self-reported questionnaires. Eur J Neurol. 2014;21:929\u201334.","DOI":"10.1111\/ene.12226"},{"key":"924_CR13","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1212\/WNL.0b013e31829a340f","volume":"81","author":"EM Lam","year":"2013","unstructured":"Lam EM, Shepard PW, St Louis EK, Dueffert LG, Slocumb N, McCarter SJ, et al. Restless legs syndrome and daytime sleepiness are prominent in myotonic dystrophy type 2. Neurology. 2013;81:157\u201364.","journal-title":"Neurology"},{"key":"924_CR14","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1056\/NEJM196412032712302","volume":"271","author":"NN Kohn","year":"1964","unstructured":"Kohn NN, Faires JS, Rodman T. Unusual manifestations due to involvement of involuntary muscle in dystrophia myotonica. N Engl J Med. 1964;271:1179\u201383.","journal-title":"N Engl J Med"},{"key":"924_CR15","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1136\/jnnp.38.10.977","volume":"38","author":"G Coccagna","year":"1975","unstructured":"Coccagna G, Mantovani M, Parchi C, Mironi F, Lugaresi E. Alveolar hypoventilation and hyperosmnia in myotonic dystrophy. J Neurol Neurosurg Psychiatry. 1975;38:977\u201384.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"924_CR16","first-page":"185","volume":"82","author":"G Coccagna","year":"1982","unstructured":"Coccagna G, Martinelli P, Lugaresi E. Sleep and alveolar hypoventilation in myotonic dystrophy. Acta Neurol Belg. 1982;82:185\u201394.","journal-title":"Acta Neurol Belg"},{"key":"924_CR17","first-page":"692026","volume":"2013","author":"A Romigi","year":"2013","unstructured":"Romigi A, Albanese M, Liguori C, Placidi F, Marciani MG, Massa R. Sleep-wake cycle and daytime sleepiness in the myotonic dystrophies. J Neurodegener Dis. 2013;2013:692026.","journal-title":"J Neurodegener Dis"},{"key":"924_CR18","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1093\/sleep\/34.2.165","volume":"34","author":"H Yu","year":"2011","unstructured":"Yu H, Laberge L, Jaussent I, Bayard S, Scholtz S, Raoul M, et al. Daytime sleepiness and REM sleep characteristics in myotonic dystrophy: a case-control study. Sleep. 2011;34:165\u201370.","journal-title":"Sleep"},{"issue":"9","key":"924_CR19","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1111\/j.1468-1331.2011.03352.x","volume":"18","author":"A. Romigi","year":"2011","unstructured":"Romigi A, Izzi F, Pisani V, Placidi F, Pisani LR, Marciani MG, et al. Sleep disorders in adult-onset myotonic dystrophy type 1: a controlled polysomnographic study. Eur J Neurol. 2011;18:1139\u201345.","journal-title":"European Journal of Neurology"},{"key":"924_CR20","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.smrv.2012.01.001","volume":"16","author":"YA Dauvilliers","year":"2012","unstructured":"Dauvilliers YA, Laberge L. Myotonic dystrophy type 1, daytime sleepiness and REM sleep dysregulation. Sleep Med Rev. 2012;16:539\u201345.","journal-title":"Sleep Med Rev"},{"issue":"1","key":"924_CR21","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1017\/cjn.2015.311","volume":"43","author":"Jean K. Mah","year":"2015","unstructured":"Mah JK, Korngut L, Fiest KM, Dykeman J, Day LJ, Pringsheim T, et al. A systematic review and meta-analysis on the epidemiology of the muscular dystrophies. Can J Neurol Sci. 2016;43:163\u201377.","journal-title":"Canadian Journal of Neurological Sciences \/ Journal Canadien des Sciences Neurologiques"},{"key":"924_CR22","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1159\/000342895","volume":"68","author":"P Shepard","year":"2012","unstructured":"Shepard P, Lam EM, St Louis EK, Dominik J. Sleep disturbances in myotonic dystrophy type 2. Eur Neurol. 2012;68:377\u201380.","journal-title":"Eur Neurol"},{"key":"924_CR23","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/ane.12355","volume":"132","author":"L Leonardis","year":"2015","unstructured":"Leonardis L, Blagus R, Dolenc GL. Sleep and breathing disorders in myotonic dystrophy type 2. Acta Neurol Scand. 2015;132:42\u20138.","journal-title":"Acta Neurol Scand"},{"issue":"6","key":"924_CR24","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1212\/01.wnl.0000453225.02417.cf","volume":"83","author":"A. Romigi","year":"2014","unstructured":"Romigi A, Placidi F, Albanese M, Izzi F, Liguori C, Mercuri NB, et al. Restless legs syndrome and daytime sleepiness are prominent in myotonic dystrophy type 2. Neurology. 2014;83:572\u20133.","journal-title":"Neurology"},{"key":"924_CR25","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s11910-018-0903-x","volume":"18","author":"A Romigi","year":"2018","unstructured":"\u2022 Romigi A, Franco V, Placidi F, Liguori C, Rastelli E, Vitrani G, et al. Comparative sleep disturbances in myotonic dystrophy types 1 and 2. Curr Neurol Neurosci Rep. 2018;18:102 The most recent comparative review regading sleep disoders in DM1 and DM2.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"924_CR26","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1097\/WCO.0000000000000128","volume":"27","author":"C Turner","year":"2014","unstructured":"Turner C, Hilton-Jones D. Myotonic dystrophy: diagnosis, management and new therapies. Curr Opin Neurol. 2014;27:599\u2013606.","journal-title":"Curr Opin Neurol"},{"issue":"6360","key":"924_CR27","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/355545a0","volume":"355","author":"Helen G. Harley","year":"1992","unstructured":"Harley HG, Brook JD, Rundle SA, Crow S, Reardon W, Buckler AJ, et al. Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy. Nature. 1992;355:545\u20136.","journal-title":"Nature"},{"key":"924_CR28","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/0092-8674(92)90154-5","volume":"68","author":"JD Brook","year":"1992","unstructured":"Brook JD, McCurrach ME, Harley HG, Buckler AJ, Church D, Aburatani H, et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3\u2032 end of a transcript encoding a protein kinase family member. Cell. 1992;68:799\u2013808.","journal-title":"Cell"},{"key":"924_CR29","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s10072-016-2805-5","volume":"38","author":"G Meola","year":"2017","unstructured":"\u2022 Meola G, Cardani R. Myotonic dystrophy type 2 and modifier genes: an update on clinical and pathomolecular aspects. Neurol Sci. 2017;38:535\u201346 A clear clinical and genetic chacterization of DM2.","journal-title":"Neurol Sci"},{"key":"924_CR30","first-page":"1889","volume":"22","author":"VA Sansone","year":"2016","unstructured":"Sansone VA. The dystrophic and nondystrophic myotonias. Continuum (Minneap, Minn). 2016;22:1889\u2013915.","journal-title":"Continuum (Minneap, Minn)"},{"issue":"10","key":"924_CR31","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/S0960-8966(03)00137-8","volume":"13","author":"G Meola","year":"2003","unstructured":"Meola G, Sansone V, Perani D, Scarone S, Cappa S, Dragoni C, et al. Executive dysfunction and avoidant personality trait in myotonic dystrophy type 1 (DM-1) and in proximal myotonic myopathy (PROMM\/DM-2). Neuromuscul Disord. 2003;13:813\u201321.","journal-title":"Neuromuscular Disorders"},{"issue":"7","key":"924_CR32","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/ejhg.2011.23","volume":"19","author":"Tiina Suominen","year":"2011","unstructured":"Suominen T, Bachinski LL, Auvinen S, Hackman P, Baggerly KA, Angelini C, et al. Population frequency of myotonic dystrophy: higher than expected frequency of myotonic dystrophy type 2 (DM2) mutation in Finland. Eur J Hum Genet. 2011;19:776\u201382.","journal-title":"European Journal of Human Genetics"},{"key":"924_CR33","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1159\/000444018","volume":"46","author":"N Vanacore","year":"2016","unstructured":"\u2022\u2022 Vanacore N, Rastelli E, Antonini G, Bianchi MLE, Botta A, Bucci E, et al. An age-standardized prevalence estimate and a sex and age distribution of myotonic dystrophy types 1 and 2 in the Rome Province, Italy. Neuroepidemiology. 2016;46:191\u20137 The first age-standardized minimun prevalence and sex and age distribution study of both DM1 and DM2 in a large European general population.","journal-title":"Neuroepidemiology"},{"key":"924_CR34","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.jsmc.2012.09.001","volume":"7","author":"MM Grigg-Damberger","year":"2012","unstructured":"Grigg-Damberger MM, Wagner LK, Brown LK. Sleep hypoventilation in patients with neuromuscular diseases. Sleep Med Clin. 2012;7:667\u201387.","journal-title":"Sleep Med Clin"},{"key":"924_CR35","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1097\/WCO.0000000000000470","volume":"30","author":"M Boentert","year":"2017","unstructured":"\u2022 Boentert M, Wenninger S, Sansone VA. Respiratory involvement in neuromuscular disorders. Curr Opin Neurol. 2017;30:529\u201337 A recent review reagarding respiratoty involvement in neuroscular diseases.","journal-title":"Curr Opin Neurol"},{"key":"924_CR36","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.nmd.2015.02.006","volume":"25","author":"M Poussel","year":"2015","unstructured":"\u2022\u2022 Poussel M, Thil C, Kaminsky P, Mercy M, Gomez E, Chaouat A, et al. Lack of correlation between the ventilatory response to CO2 and lung function impairment in myotonic dystrophy patients: evidence for a dysregulation at central level. Neuromuscul Disord. 2015;25:403\u20138 DM1 patients showed reduced ventilatory response to CO2 independent of lung function impairment and respiratory muscle weakness, suggesting a central cause of CO2 insensitivity.","journal-title":"Neuromuscul Disord"},{"key":"924_CR37","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1212\/WNL.52.8.1658","volume":"52","author":"J Mathieu","year":"1999","unstructured":"Mathieu J, Allard P, Potvin L, Pr\u00e9vost C, B\u00e9gin P. A 10-year study of mortality in a cohort of patients with myotonic dystrophy. Neurology. 1999;52:1658\u201362.","journal-title":"Neurology"},{"key":"924_CR38","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.resp.2014.01.006","volume":"193","author":"M Poussel","year":"2014","unstructured":"Poussel M, Kaminsky P, Renaud P, Laroppe J, Pruna L, Chenuel B. Supine changes in lung function correlate with chronic respiratory failure in myotonic dystrophy patients. Respir Physiol Neurobiol. 2014;193:43\u201351.","journal-title":"Respir Physiol Neurobiol"},{"key":"924_CR39","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.nmd.2015.01.011","volume":"25","author":"VA Sansone","year":"2015","unstructured":"\u2022\u2022 Sansone VA, Gagnon C. Participants of the 207th ENMC workshop. 207th ENMC workshop on chronic respiratory insufficiency in myotonic dystrophies: management and implications for research, 27-29 June 2014, Naarden, The Netherlands. Neuromuscul Disord. 2015;25:432\u201342 A consensus conference regarding chronic respiratory involvement in mytonic dystrophies. The authors reported the sole experience of NIV in DM2.","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"924_CR40","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.nmd.2011.08.010","volume":"22","author":"Alessandro Pincherle","year":"2012","unstructured":"Pincherle A, Patruno V, Raimondi P, Moretti S, Dominese A, Martinelli-Boneschi F, et al. Sleep breathing disorders in 40 Italian patients with Myotonic dystrophy type 1. Neuromuscul Disord. 2012;22:219\u201324.","journal-title":"Neuromuscular Disorders"},{"issue":"4","key":"924_CR41","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3233\/JND-180329","volume":"5","author":"Cynthia Gagnon","year":"2018","unstructured":"Gagnon C, Heatwole C, H\u00e9bert LJ, Hogrel J-Y, Laberge L, Leone M, et al. Report of the third outcome measures in myotonic dystrophy type 1 (OMMYD-3) international workshop Paris, France, June 8, 2015. J Neuromuscul Dis. 2018;5:523\u201337.","journal-title":"Journal of Neuromuscular Diseases"},{"issue":"4","key":"924_CR42","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3233\/JND-180328","volume":"5","author":"Ivo Bozovic","year":"2018","unstructured":"Bozovic I, Peric S, Pesovic J, Bjelica B, Brkusanin M, Basta I, et al. Myotonic dystrophy type 2 - data from the Serbian registry. J Neuromuscul Dis. 2018;5:461\u20139.","journal-title":"Journal of Neuromuscular Diseases"},{"key":"924_CR43","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.sleep.2012.07.001","volume":"13","author":"S Bhat","year":"2012","unstructured":"Bhat S, Sander HW, Grewal RP, Chokroverty S. Sleep disordered breathing and other sleep dysfunction in myotonic dystrophy type 2. Sleep Med. 2012;13:1207\u20138.","journal-title":"Sleep Med"},{"key":"924_CR44","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2147\/NDT.S123908","volume":"13","author":"M Banach","year":"2017","unstructured":"Banach M, Antczak J, Rola R. Association of peripheral neuropathy with sleep-related breathing disorders in myotonic dystrophies. Neuropsychiatr Dis Treat. 2017;13:133\u201340.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"924_CR45","unstructured":"American Academy of Sleep Medicine. International classification of sleep disorders. In: 3rd ed. Darien IL, editor. IL: American Academy of SleepMedicine; 2014; 53."},{"key":"924_CR46","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1136\/jnnp.2004.043455","volume":"76","author":"L Laberge","year":"2005","unstructured":"Laberge L, Gagnon C, Jean S, Mathieu J. Fatigue and daytime sleepiness rating scales in myotonic dystrophy: a study of reliability. J Neurol Neurosurg Psychiatry. 2005;76:1403\u20135.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"924_CR47","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.smrv.2011.05.002","volume":"16","author":"MM Ohayon","year":"2012","unstructured":"Ohayon MM, O\u2019Hara R, Vitiello MV. Epidemiology of restless legs syndrome: a synthesis of the literature. Sleep Med Rev. 2012;16:283\u201395.","journal-title":"Sleep Med Rev"},{"key":"924_CR48","first-page":"1938","volume":"61","author":"A George","year":"2004","unstructured":"George A, Schneider-Gold C, Zier S, Reiners K, Sommer C. Musculoskeletal pain in patients with myotonic dystrophy type 2. Arch Neurol. 2004;61:1938\u201342.","journal-title":"Arch Neurol"},{"key":"924_CR49","first-page":"572","volume":"83","author":"G Silvestri","year":"2014","unstructured":"Silvestri G, Bianchi MLE, Losurdo A, Della MG. Author response. Neurology. 2014;83:572\u20133.","journal-title":"Neurology"},{"key":"924_CR50","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1136\/jnnp.2008.165035","volume":"80","author":"L Laberge","year":"2009","unstructured":"Laberge L, B\u00e9gin P, Dauvilliers Y, Beaudry M, Laforte M, Jean S, et al. A polysomnographic study of daytime sleepiness in myotonic dystrophy type 1. J Neurol Neurosurg Psychiatry. 2009;80:642\u20136.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"924_CR51","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1212\/01.wnl.0000296827.20167.98","volume":"70","author":"E. Ciafaloni","year":"2008","unstructured":"Ciafaloni E, Mignot E, Sansone V, Hilbert JE, Lin L, Lin X, et al. The hypocretin neurotransmission system in myotonic dystrophy type 1. Neurology. 2008;70:226\u201330.","journal-title":"Neurology"},{"key":"924_CR52","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.nmd.2018.02.004","volume":"28","author":"E Bonanni","year":"2018","unstructured":"\u2022\u2022 Bonanni E, Carnicelli L, Crapanzano D, Maestri M, Simoncini C, Baldanzi S, et al. Disruption of sleep-wake continuum in myotonic dystrophy type 1: beyond conventional sleep staging. Neuromuscul Disord. 2018;28:414\u201321 A polysomnographic study regarding DM1 patients and cyclic alternating pattern analysis. The authors confirmed REM sleep dysregulation, sleep fragmentation, and nonREM alterations as expressed by slower delta power decline.","journal-title":"Neuromuscul Disord"},{"key":"924_CR53","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1212\/WNL.0b013e318259e28c","volume":"78","author":"S Chokroverty","year":"2012","unstructured":"Chokroverty S, Bhat S, Rosen D, Farheen A. REM behavior disorder in myotonic dystrophy type 2. Neurology. 2012;78:2004.","journal-title":"Neurology"},{"issue":"7","key":"924_CR54","doi-asserted-by":"publisher","first-page":"909","DOI":"10.5665\/SLEEP.1126","volume":"34","author":"Jixiong Huang","year":"2011","unstructured":"Huang J, Zhang J, Lam SP, Li SX, Ho CKW, Lam V, et al. Amelioration of obstructive sleep apnea in REM sleep behavior disorder: implications for the neuromuscular control of OSA. Sleep. 2011;34:909\u201315.","journal-title":"Sleep"},{"key":"924_CR55","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1093\/sleep\/20.9.757","volume":"20","author":"DB Rye","year":"1997","unstructured":"Rye DB. Contributions of the pedunculopontine region to normal and altered REM sleep. Sleep. 1997;20:757\u201388.","journal-title":"Sleep"},{"key":"924_CR56","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/qjmed\/hcm122","volume":"101","author":"RJ Mills","year":"2008","unstructured":"Mills RJ, Young CA. A medical definition of fatigue in multiple sclerosis. QJM. 2008;101:49\u201360.","journal-title":"QJM"},{"key":"924_CR57","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1212\/WNL.0000000000002225","volume":"85","author":"C Heatwole","year":"2015","unstructured":"\u2022 Heatwole C, Johnson N, Bode R, Dekdebrun J, Dilek N, Hilbert JE, et al. Patient-reported impact of symptoms in myotonic dystrophy type 2 (PRISM-2). Neurology. 2015;85:2136\u201346 A large survey regading DM2 burden as perceived by DM2 patients.","journal-title":"Neurology"},{"key":"924_CR58","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jns.2016.04.018","volume":"365","author":"V Rakocevic Stojanovic","year":"2016","unstructured":"\u2022 Rakocevic Stojanovic V, Peric S, Paunic T, Pesovic J, Vujnic M, Peric M, et al. Quality of life in patients with myotonic dystrophy type 2. J Neurol Sci. 2016;365:158\u201361 Evaluation of the quality of life of DM2 by disease-specific scales, demonstrating that the most severe DM2 had similar low QoL as in DM1.","journal-title":"J Neurol Sci"},{"key":"924_CR59","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1136\/jnnp.2008.156562","volume":"80","author":"AA Tieleman","year":"2009","unstructured":"Tieleman AA, den Broeder AA, van de Logt AE, van Engelen BGM. Strong association between myotonic dystrophy type 2 and autoimmune diseases. J Neurol Neurosurg Psychiatry. 2009;80:1293\u20135.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"924_CR60","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/j.1749-6632.2012.06634.x","volume":"1261","author":"N Rohleder","year":"2012","unstructured":"Rohleder N, Aringer M, Boentert M. Role of interleukin-6 in stress, sleep, and fatigue. Ann N Y Acad Sci. 2012;1261:88\u201396.","journal-title":"Ann N Y Acad Sci"},{"key":"924_CR61","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3389\/fneur.2015.00023","volume":"6","author":"A Romigi","year":"2015","unstructured":"Romigi A, Pierantozzi M, Izzi F, Desiato MT, Liguori C, Marchi A, et al. Restless legs syndrome and poliomyelitis: new evidences of an old observation? Front Neurol. 2015;6:23.","journal-title":"Front Neurol"},{"key":"924_CR62","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1111\/ene.12593","volume":"22","author":"A Romigi","year":"2015","unstructured":"\u2022\u2022 Romigi A, Pierantozzi M, Placidi F, Evangelista E, Albanese M, Liguori C, et al. Restless legs syndrome and post polio syndrome: a case-control study. Eur J Neurol. 2015;22:472\u20138 The first case-control study showing high prevalence of restless legs syndrome in post-polio syndrome.","journal-title":"Eur J Neurol"},{"key":"924_CR63","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/mus.22249","volume":"45","author":"KI Suokas","year":"2012","unstructured":"Suokas KI, Haanp\u00e4\u00e4 M, Kautiainen H, Udd B, Hietaharju AJ. Pain in patients with myotonic dystrophy type 2: a postal survey in Finland. Muscle Nerve. 2012;45:70\u20134.","journal-title":"Muscle Nerve"},{"key":"924_CR64","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.jpain.2018.03.006","volume":"19","author":"J Vliet van","year":"2018","unstructured":"\u2022\u2022 van Vliet J, Tieleman AA, Verrips A, Timmerman H, van Dongen RTM, van Engelen BGM, et al. Qualitative and quantitative aspects of pain in patients with myotonic dystrophy type 2. J Pain. 2018;19:920\u201330 Pain as a key clinical feature of DM2, as demonstrated by widespreadness of hyperalgesia in DM2.","journal-title":"J Pain"},{"key":"924_CR65","first-page":"126","volume":"34","author":"M Peric","year":"2015","unstructured":"Peric M, Peric S, Rapajic N, Dobricic V, Savic-Pavicevic D, Nesic I, et al. Multidimensional aspects of pain in myotonic dystrophies. Acta Myol. 2015;34:126\u201332.","journal-title":"Acta Myol"},{"key":"924_CR66","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1007\/s00415-011-6027-8","volume":"258","author":"AA Tieleman","year":"2011","unstructured":"Tieleman AA, Jenks KM, Kalkman JS, Borm G, van Engelen BGM. High disease impact of myotonic dystrophy type 2 on physical and mental functioning. J Neurol. 2011;258:1820\u20136.","journal-title":"J Neurol"},{"key":"924_CR67","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.ebiom.2016.03.017","volume":"7","author":"R Moshourab","year":"2016","unstructured":"Moshourab R, Palada V, Grunwald S, Grieben U, Lewin GR, Spuler S. A molecular signature of myalgia in myotonic dystrophy 2. EBioMedicine. 2016;7:205\u201311.","journal-title":"EBioMedicine"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11910-019-0924-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-019-0924-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-019-0924-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,8]],"date-time":"2020-02-08T19:23:04Z","timestamp":1581189784000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11910-019-0924-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":67,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["924"],"URL":"https:\/\/doi.org\/10.1007\/s11910-019-0924-0","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"9 February 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Andrea Romigi reports other from EISAI, personal fees from SANDOZ, personal fees from Fidia Farmaceutici, outside the submitted work. Giuseppe Vitrani received a personal fee from Fidia Farmaceutici outside the submitted work. Enrica Bonanni, Marco Caccamo, Diego Centonze, Michelangelo Maestri, Carmine Nicoletta, Alessandro Sanduzzi, and Gabriele Siciliano each declare no potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights"}}],"article-number":"9"}}